-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Kinnate Biopharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Kinnate Biopharma Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$19.3M, a 41% increase year-over-year.
- Kinnate Biopharma Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$121M, a 2.24% decline year-over-year.
- Kinnate Biopharma Inc. annual Operating Income (Loss) for 2023 was -$121M, a 2.24% decline from 2022.
- Kinnate Biopharma Inc. annual Operating Income (Loss) for 2022 was -$119M, a 31.5% decline from 2021.
- Kinnate Biopharma Inc. annual Operating Income (Loss) for 2021 was -$90.1M, a 150% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)